NCT05833178 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Helmer P, Hottenrott S, Steinisch A, Roder D, Schubert J, Steigerwald U, Choorapoikayil S, Meybohm P
Avoidable Blood Loss in Critical Care and Patient Blood Management: Scoping Review of Diagnostic Blood Loss. J Clin Med. 2022 Jan 10;11(2):320. doi: 10.3390/jcm11020320.
Siegal DM, Manning N, Jackson Chornenki NL, Hillis CM, Heddle NM
Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review. J Intensive Care Med. 2020 Oct;35(10):1074-1079. doi: 10.1177/0885066618810374. Epub 2018 Nov 27.

The Effect of Blood Tests Performed Within the Routine Protocol in the Surgical Intensive Care Unit on Hemoglobin Levels

Clinical trial NCT05833178 - References